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Abstract 
Hypertension is a global illness and one that affects circa 20% of the population.  Despite 
the effectiveness of treatment, adherence with medication is a key concern, particularly in 
the elderly. Over the last 30 years, a variety of measures have been employed to assess 
adherence and yet no one measure is deemed to be the gold standard.  Evidence suggests 
that it may be more reliable to use a combination of methods. Two forms of non-
adherence are noted; intentional and unintentional. These forms are significantly different 
with regard to underpinning characteristics and patient features. In order to improve 
adherence with antihypertensive medication a shared decision making approach should 
be adopted during patient consultation, which focuses on patients’ impressions of illness 
and underpinning health beliefs. This approach to consultation should be actively 
encouraged as part of the medication management of patients.   
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Introduction 
Hypertension is a ubiquitous problem in older adults.  In Western countries, hypertension 
is a disease that affects more than 20% of the population and is a major risk factor for 
cardiovascular morbidity and mortality1. Compared to normotensive patients, 
hypertension presents significant cardiovascular risk to patients. According to current 
guidelines, 67% of older people are likely to require treatment for hypertension2. Drug 
therapy is a central feature of hypertension management and should aim to normalize or 
reduce the risks of hypertension derived morbidity and mortality. Even though, treatment 
with antihypertensive medication can reduce the risk of stroke by 31 % to 45% patients 
often have to be persuaded of the long and short–term health benefits to be gained from 
adherence to pharmacological treatment3,4. The fact that treatment for hypertension is 
readily available and the efficacy of treatment is well established, poor control of 
hypertension is a major health problem that is frequently manifested in late life5. A recent 
study identified that of the 700,000 patients diagnosed with hypertension only 132,000 
were well controlled6. Efforts have been made to reduce ‘therapeutic inertia’ particularly 
in patients with modestly systolic blood pressure levels. One of the major causes of 
uncontrolled hypertension is failure to take medicines as directed by the physician. This 
may be because hypertensive patients are often asymptomatic, therefore stop taking their 
medication as they cannot see the benefit to be gained from taking medicines 7. It is 
estimated that up to 50% of patients fail to adhere to medication regimens sufficient to 
maintain their blood pressure within recommended limits 8-9. 
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Method 
The aim of this review is to examine medication taking behaviour in relation to 
antihypertensive medication. This review was restricted to a review of the current 
literature and draws on established methods. This review of the literature provides an 
evaluation of the range of existing research relevant to adherence with anti-hypertensive 
medication. The aim of this review is not to evaluate the quality of the studies reported 
but to provide a succinct account of the range of existing studies and literature relevant to 
the subject of medication adherence and antihypertensive medication.  
The following databases were searched to inform the review: Pubmed, Cinahl, Google 
scholar, advanced Google scholar, Medline, Medicines Partnership, The Cochrane 
Library, The King’s Fund, RCN database and the World Health Organisation. Hand 
searching of individual journals which could supply additional literature was also 
undertaken. A defined search strategy was undertaken using a combination of search 
terms, e.g ‘antihypertensive therapy and adherence’, ‘antihypertensive medication and 
adherence’, ‘blood pressure medication and adherence with medication, health beliefs 
and medicines, values and medicines, perceptions of medicines, medication management 
and hypertensive medication. References were selected from 1980 until 2008, as it was 
believed that most relevant studies would be found within this period. The study drew on 
both UK based and international literature in an attempt to illuminate the complexity and 
depth of the subject and to illustrate the global nature of the subject matter.   
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Papers were included if they were published between 1980 and 2008, were written in 
English, and focused on the determinants of adherence with medication in patients being 
treated for hypertension.  
 
Research studies were included in the review if they addressed the central question what 
are people’s beliefs, attitudes and views pertinent to adherence with anti-hypertensive 
medication .The papers included used a variety of research designs: pilot studies, meta-
analyses, systematic reviews, questionnaire surveys, randomized controlled trials, cohort 
studies, and a range of exploratory quantitative studies, and a qualitative study reporting 
the syntheses of qualitative studies. As studies differed in outcomes measures employed, 
time scale involved, and results, no meta analysis was possible. For this reason a 
narrative synthesis of the evidence was undertaken as this allowed subjective analysis and 
judgments of the relative merits of papers specific to the aim and objectives of the study.  
This analysis did not seek to examine the heterogeneity of studies or to describe the 
quality and rigour of the study designs employed but aimed to draw on the salient 
findings and merit of the individual studies and their contribution to the subject area in 
order to present an overview of the existing research.  
 
Papers were appraised using a version of the Critical Appraisal Skills Programme 
(Critical Appraisal Skills Programme, 1998). Using this method, studies were excluded if 
they were judged to be insufficiently focused on medication adherence or did not focus 
specifically on individuals with hypertension.  
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Four key themes emerged from the literature: adherence to medication and measures used 
to assess it, patient beliefs about medication, intentional non-adherence and unintentional 
non-adherence. 
 
Measures of adherence   
Adherence is described as “the extent to which a patient’s behaviour in terms of taking 
medicines, following diets or executing lifestyle changes, coincides with advice given by 
health care professionals” (p.20)10.  Up till now the majority of investigative research on 
patients and their medication taking behaviour has focused on methods that can be used 
to predict or measure subgroups of individuals who may be non-adherent with the 
medication 7,11,12. There are no gold standard measures of assessing adherence with 
medication. Methods include indirect clinical observations such as drug–assays from 
urine or serum. These approaches are intrusive and costly. Other approaches include pill 
counting13, self report14, collateral reports which question families and carers, pharmacy 
records, appointment keeping and drug diaries. Pill counting may identify errors in dose 
and timing but it can be fraught with adequate monitoring problems. Patient assessment 
at disease management clinics can be adversely influenced by clinic non-attenders and 
poor response to medicines14, 15. Medication adherence assessment by urine and serum 
drug-assays and blood pressure measurements has been criticized for its failure to provide 
compelling or useful information and are viewed as short-term assessments4. There is 
also a poor correlation between blood pressure measurements and self-reported 
adherence16. Electronic monitoring is a useful addition to pill counting as it offers an 
indication of the patient’s patterns of medication taking as well as producing reliable and 
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objective results17. This approach has been used to assess adherence to antihypertensive 
drugs in Afro-Americans and young people13, 18. By comparison, self report is a more 
objective measure of long–term commitment to drug adherence as patients can be 
interviewed directly19.  
 
Structured interviewing has been successfully used to develop a medication adherence 
self–reported tool to assess adherence with medication20 and to assess medication 
complexity 21.This medication complexity index score is dependent on the frequency of 
all medicines taken in one day added to the daily total quantity of medicines plus any 
medication administration requirements22. Pill counting fails to take into account when 
pills were dispensed, hoarding and caches of pills in other locations, or sharing of pills 
among relatives15 . In addition to this scoring outcomes can be adversely influenced by 
partial adherence with medication. Structured interviewing had been used to explore 
hypertensive patients’ views on medication taking behaviour and rapport difficulties with 
physician. Patients who had a positive experience with medical practitioners were more 
likely to adhere to and acknowledge the perceived benefits of antihypertensive 
medication23, 24. A drawback of using structured interviewing is the hawthorn effect 
where non-complaint patients tell the researcher what they want to hear or provides 
unrealistic views during interview25. To escape possible problems of this kind, a more 
successful approach would include a combination of blood pressure measurements, 
serum drug assays and structured interviewing4.   
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Patient beliefs about medication 
Adherence to medication is a critical factor in the continued health and well-being of 
patients with hypertension. The patients’ acceptance of health care advice and perception 
of medicines management may be influenced by their subjective beliefs about their 
illness or illness attribution26. The may result in decreased reliance on medication and 
subsequent non-adherence especially in middle aged and very old patients27. The 
contribution of illness representation and theory of planned behaviour and reasoned 
action is debated. Reasoned action refers to the role of patients’ perceptions of control, 
intentions, attitudes and social pressure and its impact on medication taking behaviour. 
Study findings are conflicting. A recent study suggests that patients understanding of 
their illness and psychosocial factors are unrelated to adherence with medication whereas 
others have found that personality, self efficacy and a positive attitude to disease 
management assisted the self regulation of medicines26,28. Challenging the patient’s 
health belief can result in non-adherence especially if patients view hypertension as an 
intermittent illness which requires ephemeral treatment4,29   
 
The physician patient consultation can be one way of promoting understanding of the 
patients’ perceptions of illness, views, experiences, beliefs and opinions of treatment 4, 24, 
30
, and attitudes towards hypertension,31. Exploration of these issues can help to 
implement effective preventative strategies,29.  Overall the ultimate goal of medication 
management in hypertension should involve shared decision making between the patient 
and the prescriber 32, 33. However, this process can take time and skills that enable 
 8
practitioners to build a relationship with the patient that is based on negotiation and 
addresses the inequalities in patient choice34. 
 
 Non-adherence with medication 
 
Non-adherence with medication can take two forms; intentional non-adherence which is 
the deliberate omission of medicines due to health beliefs, faith in the prescriber, 
comprehension of the condition and role of medicines in medication management or due 
to previous experience of being managed. The second form is unintentional non-
adherence which is a random departure from medication taking leading to medication 
omissions from a prescribed treatment regimen4.   
 
Unintentional non-adherence  
The salient features of unintentional non-adherence focus on altering medication 
contingent on self assessment of mental health, self perceptions of stress or anxiety, being 
asymptomatic and not requiring medication, cognitive impairment, forgetting to take 
medicines or simply altering the doses of medicines to fit in with daily chores 22, 35.  
Lifestyle events and adherence patterns are especially prominent in studies in older 
people4,36. Access to medicines is also an influential factor. The dexterity of patients in 
relation to manipulating dosett boxes, child-proof containers, blister packs and ability to 
distinguish the colours of tablets and read prescription labels with font size 10 has been 
accessed to investigate. In this respect, only 8% of older people successfully managed all 
the tasks, 33% could not read a dot matrix prescription label or differentiate coloured 
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medicines and 29% could not open child proof container 22. In terms of knowledge, 67% 
of older people experienced errors in naming or identifying at least one of their 
medicines. Unintentional non-adherence can be addressed through simpler dosage 
regimens and involving carer’s and their families in medication administration if 
possible22. 
Intentional non-adherence  
 
There are numerous reasons for intentional non-adherence with antihypertensive 
medication; ethical, moral issues, life priorities, individualistic approaches to maintaining 
and controlling one’s health35, high levels of independence,26, complicated drug 
regimens, lack of motivation due to continuous therapy, deficient comprehension of the 
role of medication in the management of hypertension. Also the development or 
anticipation of medication related side effects which is a common problem in 
hypertensive patients. Many hypertensive patients bewail that specific medicines were 
worse than the disease itself4. Circa 64% of patients requested a change in anti-
hypertensive medication due to medication induced sleeping problems, nightmares, 
cough, nausea or swollen ankles. Other side effects include dizziness, flushing and 
oedema, rapid pulse, shortness of breath and increased urination24,36. However intentional 
non-adherence also occurs due to a general dislike and feeling unnatural taking 
medicines, having to facilitate lifestyle changes. Many patients requested a change or an 
adjustment in medication to reverse these issues.  
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Associations have also been made to modifiable factors such as depressive or psychiatric 
illness and polypharmacy and non–modifiable factors such as age, gender and ethnicity 
28
. Recently, it has been shown that a correlation exists between poor adherence and older 
patients of female gender who administer more than two medicines daily37. These 
findings contrast with published reports that found that polypharmacy, older age and 
shared decision making improved adherence with medication12. This result may be due to 
the impact of improved communication between prescriber and patient. At the other end 
of the age spectrum, non-adherence with medication correlated negatively with young 
age, female gender, recent commencement of therapy combined with elevated blood 
pressure and concurrent administration of medicines 12, 38.  
 
Afro-Caribbean or African American hypertensive patients are increasingly likely to 
diversify their medication taking behavior dependent on feelings of wellbeing and 
individual estimations of blood pressure control, dislike of taking medicines and fears of 
addiction. Afro-Caribbean men appear to have a tendency to titrate their medicines with 
traditional remedies according to their perceived symptoms. Associations have been 
made between illness attributions, perceptions of the contribution of medicines in the 
management of their blood pressure and intentional non-adherence. Correlations between 
medication non-adherence have also been found in patients with poor education, diabetes 
and financial difficulties. Intentional non-adherence with medication can be improved by 
patient motivational strategies that address issues and possible barriers 39.   
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Conclusion 
This review concludes that the measures used to assess adherence with anti-hypertensive 
medication are diverse. Benefits can be gained by combining traditional serum and urine 
analysis and blood pressure measurements with structured interviewing techniques or self 
evaluation 22.  
 
Illness attributions are important and their impact on management outcomes needs to be 
challenged.  A recent study found that physicians and patients could agree that 
hypertension management and the prevention of cardiac events were important concerns 
but differed in relation to side effect management strategies39. The recognition and 
development of side effects is a key concern and one of the central causes of intentional 
non-adherence40. Raising awareness of the possibility of side effects and related risks to 
patients, one can directly challenge intentional non-adherence. Reducing the complexity 
of the medication regimen can be influential in improving adherence in hypertensive 
patients. Unintentional adherence is mainly due to forgetfulness and change in routine. 
By comprehending the factors known to lead to non-adherence with medication, health 
care providers can target preventative interventions 28.   
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